From the Wires
Global Metabolomics Market Worth $1.5 Billion by 2017
Jan. 11, 2013 06:30 AM
DALLAS, January 11, 2013 /PRNewswire/ --
The report "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017", analyses the global metabolomics market by region, applications and indications with five year revenue forecasts. It also identifies the factors driving and restraining the global metabolomics market with analysis of trends, opportunities and challenges.
The market is segmented and the revenue is forecasted on the basis of major regions such as America, Europe, Asia and Rest of the World (ROW) covering the key countries for each region. Further, the market is also segmented and revenues are forecasted on the basis of applications and disease indications.
Browse 11 market data tables and 36 figures spread through136 slidesand in-depth TOC on "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) -Forecasts from 2012 to 2017"
http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html
Early buyers will receive 10% customization on reports.
In the post genomic era, metabolomics is gaining importance as another promising "omic" technology for understanding the biology of various diseases. Rapid advancement has been occurring in prediction, detection, monitoring and understanding of various diseases using metabolomic technologies.
The market for metabolomic data analysis tools and software is increasing at a higher rate. Metabolomics allows pharma companies to stretch their R&D efforts by improving efficiency in target discovery and validation, mode-of-action, and toxicology studies. There has been a significant global growth in biotechnology and pharmaceutical industries in the last decade and the market is expected to have a double-digit growth rate in the coming years.
Biomarker discovery services and increased need for toxicity testing are driving the metabolomics market. Nutraceuticals, plant genomics, nutri-genomics, and systems biology are some high growth and emerging application areas that are expected to drive the global market of metabolomics in coming years. The global market for metabolomics in terms of revenue is estimated to be worth $343 million in 2012 and is expected to reach $1.5 billion by 2017, growing at a CAGR of 35% from 2012 to 2017.
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices [ http://www.marketsandmarkets.com/medical-device-market-research-11.html ], pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com
http://twitter.com/marketsmarkets
http://www.facebook.com/MarketsandMarkets
http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
About PR NewswireCopyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
.gif)
Despite the great interest in SaaS and cloud, many large enterprises are still grappling with the right mixture of on-premises, hosted and various cloud deployment models for their applications, infrastructure and data. And the formula for picking which apps and assets should run...
MetraTech Corp., a provider of Agreements-Based Billing, Commerce and Compensation solutions, on Tuesday announced that Achilles, a global software-as-a-service (SaaS) provider of supply chain management services, has selected the MetraNet billing and settlement platform to suppo...
The personal cloud will be the main catalyst in bringing services otherwise unavailable to developing nations.
While businesses have been deploying cloud technology for some time, it's only recently that personal cloud services have emerged. The rise of the personal cloud means ...
Over the weekend Barron’s put out a piece touting AMD’s chances of taking share in the mainstream server market that belongs to Intel with its SeaMicro microserver acquisition, a development that would tickle its tiny stock price, if it ever happened. But even the thought of it, ...
Cloud computing is the game changer for the life sciences industry, according to an article on PharmaBiz.com.
Globally, pharma majors are deploying cloud technology because it provides data security, compliance and transparency, according to Vikram Anand, associate vice presiden...
